Eltrombopag in Good's Syndrome.

Abstract

Good's syndrome is a rare acquired immunodeficiency associated with thymoma. Eltrombopag is a thrombopoietin receptor agonist and has been shown to be a valuable supplement to the treatment of several types of refractory cytopenias. In this paper, we describe a male patient suffering from Good's syndrome with immune-mediated T-cell driven pancytopenia and absence of megakaryopoiesis. He was successfully treated with eltrombopag resulting in a multilineage clinical response.

• Authors: Håvard Anton Kristiansen, Signe Spetalen, Yngvar Fløisand, Dag Heldal
• Journal: Case reports in hematology (Case Rep Hematol) Vol. 2014 Pg. 172139 ( 2014) ISSN: 2090-6560 [Print] United States
• PMID: 25389501 (Publication Type: Journal Article)